Synthesis, characterization and antimicrobial activity evaluation of new 2,4-Thiazolidinediones bearing imidazo[2,1-b][1,3,4]thiadiazole moiety

Arabian Journal of Chemistry

Volumn 4, Issue 4, 2011, Pages 465-472

  Alagawadi, Kallanagouda R ^a   Alegaon, Shankar G ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Antibacterial activity; Antifungal activity; Arylimidazo 2,1 b 1,3,4 thiadiazole 2 sulfonamide; Thiadiazole; Thiazolidinedione (TZD)

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTI-FUNGAL ACTIVITY; ARYLIMIDAZO[2,1-B][1,3,4]THIADIAZOLE-2-SULFONAMIDE; THIADIAZOLES; THIAZOLIDINEDIONES;

MICROORGANISMS; SULFUR COMPOUNDS;

ORGANIC COMPOUNDS;

EID: 80053250964     PISSN: 18785352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arabjc.2010.07.012     Document Type: Article

References (23)

1. Andreani A., Rambaldi M., Locatelli A., Leoin A., Bossa R., Chiericozzi M., Galatulas I., Salvatore G. Eur. J. Med. Chem. 1993, 28:825-829.
2. Andreani A., Leonia A., Locatelli A., Morigi R., Rambaldi M., Simon W.A., Senn-Bilfinger J. Arzneimittelforschung 2000, 50:550-553.
3. Andotra C.S., Langer T.C., Kotha A. J. Ind. Chem. Soc. 1997, 72:125-127.
4. Ayhan-Kilcigil G., Altanlar N. Arzneimittelforschung. 2000, 50:154-157.
5. Bozdag-Dundar O., Ozgen O., Mentese A., Altanlar N., Atli O., Kendi E., Ertan R. Bioorg. Med. Chem. 2007, 15:6012-6017.
6. Boschelli D.H., Connor D.T., Kuipers P.J., Wright C.D. Bioorg. Med. Chem. Lett. 1992, 2:705-708.
7. Chopra I., Schofield C., Everett M., O'Neill K., Miller K., Wilcox M. Lancet Infect. Dis. 2008, 8:133-139.
8. Cantello B.C.C., Cawthorne M.A., Cottam G.P., Duff P.T., Haigh D., Hindley R.M., Lister C.A., Smith S.A., Thurlby P.L. J. Med. Chem. 1994, 37:3977-3985.
9. Dessen A., Di Guilmi A.M., Vernet T., Dideberg O. Curr. Drug. Targets Infect. Disord. 2001, 1:63-77.
10. De-Lima J.G., Perrissin M., Chantegrel J. Arzneimittelforschung 1994, 44:831-834.
11. Gadad A.K., Mahajanshetti C.S., Nimbalkar S., Raichurkar A. Eur. J. Med. Chem. 2000, 35:853-857.
12. Heerding D.A., Christmann L.T., Clark T.J., Holmes D.J., Rittenhouse S.F., Takata D.T., Venslavsky J.W. Bioorg. Med.Chem. Lett. 2003, 13:3771-3773.
13. Khazi I.A.M., Mahajanshetti C.S., Gadad A.K., Tarnalli A.D., Sultanpur C.M. Arzneimittelforschung 1996, 46:949-952.
14. Kolavi G., Hegde V., Khazi I.M., Gadad P. Bioorg. Med. Chem. 2006, 14:3069-3080.
15. Muroi H., Nihei K., Tsujimoto K., Kubo I. Bioorg. Med. Chem. 2004, 12:583-587.
16. National Committee for Clinical Laboratory Standards, 2000. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard document M-7: A5. National Committee for Clinical Laboratory Standards.
17. Pfeltz R.F., Wilkinson B.J. Curr. Drug. Targets Infect. Disord. 2004, 4:273-294.
18. Roberts M.C. Curr. Drug. Targets Infect. Disord 2004, 4:207-215.
19. Tenover F.C., McDonald L.C. Curr.Opin. Infect. Dis. 2005, 18:300-305.
20. Terashima H., Hama K., Yamamoto R., Tsuboshima M., Kikkawa I., Shigata Y. J. Pharmacol. Exp. Ther. 1984, 229:226-230.
21. Terzioglu N., Gursoy A. Eur. J. Med. Chem. 2003, 38:781-786.
22. Tuncbilek M., Altanlar N. Arch. Pharm. Chem. Life Sci. 2006, 339:213-216.
23. Yoshioka T., Fujita T., Kanai T., Aizawa Y., Kurumada T., Hasegawa K., Horikoshi H. J. Med. Chem. 1998, 32:421-428.